Preparation & Measurement Guide

Ipamorelin 5mg Dosage Protocol

Preparation, measurement, commonly documented protocol ranges, and storage for a Ipamorelin 5mg vial.

Research use only Educational summary of a commonly documented convention. Not approved for human use.
Vial Size Ipamorelin 5mg
Preparation 1mL bacteriostatic water
Concentration 5mg/mL after preparation
Documented Convention 100-200mcg once daily

1. Preparation and Measurement

Ipamorelin 5mg With 1mL of Diluent

Add 1mL of bacteriostatic water to the vial. The resulting concentration is 5mg/mL. On a U-100 syringe, each unit contains 50mcg.

5mg / 1mL = 5mg/mL
1 U-100 unit = 0.01mL = 50mcg

Preparation

  1. Draw 1mL of bacteriostatic water using sterile equipment.
  2. Let the liquid run slowly down the inside wall of the vial.
  3. Gently swirl until dissolved. Do not shake.
  4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in circulated protocols. Frequency: once daily.

Period Documented amount Measurement
Weeks 1-2 100mcg once daily 0.02mL / 2 units
Weeks 3-4 150mcg once daily 0.03mL / 3 units
Weeks 5-8 200mcg once daily 0.04mL / 4 units

Vial estimate: One 5mg vial contains approximately 50 administrations at the first listed amount or 25 at the final listed amount.

Practical Notes

  • The table applies only to this vial prepared with exactly 1mL.
  • Some entries are very small measurements; account for the accuracy of the measuring device.
  • Record the amount, date, and preparation used.

3. Supplies Needed

  • Ipamorelin 5mg vial.
  • 1mL of bacteriostatic water per vial.
  • Sterile U-100 syringes.
  • Alcohol swabs.
  • Sharps container.

4. Storage and Handling

  • Keep unopened vials cool, dry, dark, and protected from moisture.
  • After preparation, refrigerate at 2-8 degrees C.
  • Protect from light and avoid repeated freeze-thaw cycles.
  • Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

Ipamorelin is a growth-hormone secretagogue studied in experimental pharmacology and early human research. The available literature does not establish a standard therapeutic protocol.

Ipamorelin is not an approved therapeutic drug. The staged schedule records a commonly circulated convention for comparison.

Primary Research and Regulatory References

  1. Ipamorelin growth-hormone secretagogue study
  2. Ipamorelin pharmacology study

Research Materials

Review Ipamorelin 5mg Product Information

← Back to Dosage Protocols

Research-use disclaimer: Ipamorelin 5mg products sold by Vialcrest are intended strictly for laboratory research. They are not intended for human consumption, injection, therapeutic use, medical use, diagnostic use, or veterinary use. This article documents how a commonly circulated or published convention is described for educational comparison. It does not endorse that convention, establish safety or efficacy, or provide medical advice.